13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurogenetics
The field of neurogenetics is dedicated to understanding the role of genetics in the development and progression of neurological disorders. Researchers are uncovering how mutations in specific genes lead to a wide range of conditions, from rare inherited diseases to more common neurological disorders like multiple sclerosis and Parkinson’s disease. The use of advanced technologies, such as genome-wide association studies (GWAS), is helping to identify new genetic variants associated with neurological diseases, offering insights into their underlying causes. Furthermore, the advent of gene therapy and genome editing techniques is providing new hope for treating genetic neurological conditions by correcting or replacing faulty genes. The study of epigenetics also plays a vital role in understanding how environmental factors influence genetic expression in the brain.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Younok Dumortier Shin
OnusBio, United States
Jessica Marchant
Texas Woman's University, United StatesSubmit your abstract Today
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Compromised psychophysical orientation to the vertical gravitational constant and its role in the emergence of complex neurological and mental disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title :
Ursula Abu Nahla, Hebron University, State of Palestine
Title : The efficacy and safety of Rimegepant every other day as preventive treatment for migraine: A systematic review and meta-analysis of randomized controlled trials
Abdalmajed Alqsair, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia
Title : Rewiring recovery: Effect of repetitive transcranial magnetic stimulation on neuropsychological outcomes following mild to moderate traumatic brain injury
Kumari Shaloo, All India Institute of Medical Sciences Raebareli, India